METABOLIC REGULATION OF INFLAMMATION BY MICROBIAL-DERIVED SHORT CHAIN FATTY ACIDS
微生物衍生的短链脂肪酸对炎症的代谢调节
基本信息
- 批准号:9027837
- 负责人:
- 金额:$ 34.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-01 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcetatesAcuteAgonistAmericanAnimalsAntigensBacteriaButyratesCell LineCell physiologyChronicColonCommunicationCrohn&aposs diseaseDevelopmentDiseaseDisease ProgressionDisease modelEnergy-Generating ResourcesEpithelialEpithelial CellsEpitheliumEventFormulationGastrointestinal tract structureGenesGoalsHealedHealthHomeostasisHypoxiaHypoxia Inducible FactorImmune responseIn VitroIndividualInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInflammatory disease of the intestineInterleukin-10Intestinal DiseasesIntestinal MucosaIntestinesLeadMapsMediatingMetabolicMetabolic PathwayMetabolismModelingMolecularMucositisMucous MembraneMusOutcomeOxygenPathway interactionsPhysiologicalPositioning AttributePropionatesReceptor SignalingRegulationReportingResearch DesignResolutionRoleSignal TransductionSubmucosaTNF geneTestingTissuesUlcerative ColitisVolatile Fatty AcidsWorkWound Healingbasecommensal microbesdefined contributiondesigngut microbiotahealinghypoxia inducible factor 1in vitro Modelin vivoin vivo Modelinsightinterestmicrobialmicrobial hostmicrobiotanew therapeutic targetnovelreceptorreceptor expressionresearch studyresponsetooltributyrin
项目摘要
DESCRIPTION (provided by applicant): Mucosal diseases such as Inflammatory Bowel Disease (IBD) result from changes in the microbiota (dysbiosis) in the face of ongoing inflammation. Our ongoing studies have identified a significant role for microbial-derived short chain fatty acids (SCFA) in intestinal disease and an important role for the transcriptional regulator hypoxia-inducible factor (HIF) in protection during intestinal inflammation. It remains unclear exactly how the host and the microbiota communicate and whether such communication is relevant to disease progression or inflammatory resolution. This study is designed to test the hypothesis that host-microbial crosstalk via SCFA promotes mucosal integrity, with HIF as the epithelial messenger and the epithelial IL-10R as the target. Three integrated specific aims are proposed to test this hypothesis. First, we will define the SCFA signaling axis for HIF stabilization using an established intestinal epithelial model in vitro and in vivo. Specifically, e will define how the epithelial SCFA signaling receptor GPR109a and impacts HIF stabilization in the mucosa and how such signaling promotes mucosal integrity. Second, we will elucidate the contribution of SCFA-induced HIF on epithelial IL-10R expression and signaling. Third, we will determine the relevance of this SCFA-HIF-IL-10R axis in mucosal inflammatory models. The overall aim of this proposal is to elucidate the host-microbial communication events mediating mucosal epithelial responses to inflammation.
描述(由申请人提供):炎症性肠病 (IBD) 等粘膜疾病是由于持续炎症导致微生物群发生变化(菌群失调)所致。我们正在进行的研究已确定微生物衍生的短链脂肪酸具有重要作用。 SCFA)在肠道疾病中的作用以及转录调节因子缺氧诱导因子(HIF)在肠道炎症保护中的重要作用目前尚不清楚宿主和微生物群如何进行沟通和交流。这种通讯是否与疾病进展或炎症消退相关,本研究旨在检验以下假设:以 HIF 为上皮信使,以上皮 IL-10R 为靶标,通过 SCFA 进行宿主微生物串扰可促进粘膜完整性。首先,我们将使用已建立的体外和体内肠上皮模型来定义 HIF 稳定的 SCFA 信号轴。 SCFA 信号受体 GPR109a 并影响粘膜中的 HIF 稳定性,以及这种信号如何促进粘膜完整性。其次,我们将阐明 SCFA 诱导的 HIF 对上皮 IL-10R 表达和信号传导的贡献。第三,我们将确定该 SCFA 的相关性。 -粘膜炎症模型中的 HIF-IL-10R 轴该提案的总体目标是阐明介导宿主-微生物通讯事件。粘膜上皮对炎症的反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sean P Colgan其他文献
Sean P Colgan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sean P Colgan', 18)}}的其他基金
Gut microbiome effects on intestinal barrier function and metabolic syndrome in HIV positive men who have sex with men
肠道微生物群对男男性行为艾滋病毒阳性男性肠道屏障功能和代谢综合征的影响
- 批准号:
10674923 - 财政年份:2022
- 资助金额:
$ 34.66万 - 项目类别:
Gut microbiome effects on intestinal barrier function and metabolic syndrome in HIV positive men who have sex with men
肠道微生物群对男男性行为艾滋病毒阳性男性肠道屏障功能和代谢综合征的影响
- 批准号:
10527542 - 财政年份:2022
- 资助金额:
$ 34.66万 - 项目类别:
METABOLIC REGULATION OF INFLAMMATION BY MICROBIAL-DERIVED SHORT CHAIN FATTY ACIDS
微生物衍生的短链脂肪酸对炎症的代谢调节
- 批准号:
9242634 - 财政年份:2015
- 资助金额:
$ 34.66万 - 项目类别:
Metabolic Regulation of Inflammation by Microbial-Derived Short Chain Fatty Acids
微生物衍生的短链脂肪酸对炎症的代谢调节
- 批准号:
9897168 - 财政年份:2015
- 资助金额:
$ 34.66万 - 项目类别:
METABOLIC CONTROL OF EPITHELIAL AUTOPHAGY DURING INFLAMMATION
炎症过程中上皮自噬的代谢控制
- 批准号:
9274257 - 财政年份:2015
- 资助金额:
$ 34.66万 - 项目类别:
Metabolic Regulation of Inflammation by Microbial-Derived Short Chain Fatty Acids
微生物衍生的短链脂肪酸对炎症的代谢调节
- 批准号:
10375388 - 财政年份:2015
- 资助金额:
$ 34.66万 - 项目类别:
METABOLIC CONTROL OF EPITHELIAL AUTOPHAGY DURING INFLAMMATION
炎症过程中上皮自噬的代谢控制
- 批准号:
9066687 - 财政年份:2015
- 资助金额:
$ 34.66万 - 项目类别:
Metabolic Regulation of Inflammation by Microbial-Derived Short Chain Fatty Acids
微生物衍生的短链脂肪酸对炎症的代谢调节
- 批准号:
10601042 - 财政年份:2015
- 资助金额:
$ 34.66万 - 项目类别:
相似国自然基金
线粒体ClpP激动剂通过铁死亡-免疫调控cross-talk治疗急性髓细胞白血病的机制研究
- 批准号:82370171
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于FACS的AT1R偏向性激动剂的超高通量筛选
- 批准号:31600628
- 批准年份:2016
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
PPAR-α激动剂在急性心肌梗死中调控巨噬细胞极化促进血管生成的机制研究
- 批准号:81500267
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
β2肾上腺素能受体激动剂通过cAMP/PKA通路调控MSCs旁分泌在急性肺损伤修复中的作用和机制
- 批准号:81500058
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Small molecule therapies targeting chromatin architecture in heart failure
针对心力衰竭染色质结构的小分子疗法
- 批准号:
10312765 - 财政年份:2019
- 资助金额:
$ 34.66万 - 项目类别:
Small molecule therapies targeting chromatin architecture in heart failure
针对心力衰竭染色质结构的小分子疗法
- 批准号:
10534162 - 财政年份:2019
- 资助金额:
$ 34.66万 - 项目类别: